These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis. Wang Y, Sun Y, Wu A, Xu S, Pan R, Zeng C, Jin X, Ge X, Shi Z, Ahola T, Chen Y, Guo D. J Virol; 2015 Aug 16; 89(16):8416-27. PubMed ID: 26041293 [Abstract] [Full Text] [Related]
47. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors. Riccio AA, Sullivan ED, Copeland WC. J Biol Chem; 2022 Jan 16; 298(1):101518. PubMed ID: 34942146 [Abstract] [Full Text] [Related]
48. The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors. Otava T, Šála M, Li F, Fanfrlík J, Devkota K, Perveen S, Chau I, Pakarian P, Hobza P, Vedadi M, Boura E, Nencka R. ACS Infect Dis; 2021 Aug 13; 7(8):2214-2220. PubMed ID: 34152728 [Abstract] [Full Text] [Related]
49. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. Baddock HT, Brolih S, Yosaatmadja Y, Ratnaweera M, Bielinski M, Swift LP, Cruz-Migoni A, Fan H, Keown JR, Walker AP, Morris GM, Grimes JM, Fodor E, Schofield CJ, Gileadi O, McHugh PJ. Nucleic Acids Res; 2022 Feb 22; 50(3):1484-1500. PubMed ID: 35037045 [Abstract] [Full Text] [Related]
50. Utilization of the EpiMed Coronabank Chemical Collection to identify potential SARS-CoV-2 antivirals: in silico studies targeting the nsp14 ExoN domain and PLpro naphthalene binding site. Liang JJ, Pitsillou E, Lau HLY, Mccubbery CP, Gan H, Hung A, Karagiannis TC. J Mol Graph Model; 2024 Sep 22; 131():108803. PubMed ID: 38815531 [Abstract] [Full Text] [Related]
51. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme. Ahmad S, Waheed Y, Ismail S, Bhatti S, Abbasi SW, Muhammad K. Molecules; 2021 Mar 07; 26(5):. PubMed ID: 33800013 [Abstract] [Full Text] [Related]
52. Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16). Kumar M, Roy A, Rawat RS, Alok A, Tetala KKR, Biswas NR, Kaur P, Kumar S. J Biomol Struct Dyn; 2022 Mar 07; 40(24):13965-13975. PubMed ID: 34766876 [Abstract] [Full Text] [Related]
53. Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2. Balieiro AM, Anunciação ELS, Costa CHS, Qayed WS, Silva JRA. Int J Mol Sci; 2022 Nov 12; 23(22):. PubMed ID: 36430451 [Abstract] [Full Text] [Related]
54. Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication. Ogando NS, El Kazzi P, Zevenhoven-Dobbe JC, Bontes BW, Decombe A, Posthuma CC, Thiel V, Canard B, Ferron F, Decroly E, Snijder EJ. Proc Natl Acad Sci U S A; 2021 Dec 07; 118(49):. PubMed ID: 34845015 [Abstract] [Full Text] [Related]
55. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Krafcikova P, Silhan J, Nencka R, Boura E. Nat Commun; 2020 Jul 24; 11(1):3717. PubMed ID: 32709887 [Abstract] [Full Text] [Related]
56. Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity. Case JB, Ashbrook AW, Dermody TS, Denison MR. J Virol; 2016 Aug 15; 90(16):7248-7256. PubMed ID: 27252528 [Abstract] [Full Text] [Related]
57. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2. Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ. J Virol; 2020 Nov 09; 94(23):. PubMed ID: 32938769 [Abstract] [Full Text] [Related]
58. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes. Ornelas MY, Thomas AY, Johnson Rosas LI, Scoville RO, Mehta AP. ACS Synth Biol; 2022 Nov 18; 11(11):3759-3771. PubMed ID: 36331143 [Abstract] [Full Text] [Related]
59. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2. Sharma K, Morla S, Goyal A, Kumar S. Life Sci; 2020 Oct 15; 259():118169. PubMed ID: 32738360 [Abstract] [Full Text] [Related]
60. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. Lim SV, Rahman MB, Tejo BA. BMC Bioinformatics; 2011 Oct 15; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]